Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no ...

10月7日，代表复方药房的行业组织外包设施协会 (Outsourcing Facilities Association)向德克萨斯州的一家联邦法院提起诉讼，声称FDA在剥夺消费者获得替西肽的权利方面做出了“鲁莽和武断的决定”。该组织声称替西帕肽仍然供应不足，并要求FDA撤销其决定。

The FDA said in a court filing late Friday that it would allow pharmacists to continue making compounded versions of ...

Unemployed to be given weight-loss jab to help them back into work - The new trial aims to gather evidence of the effects of ...

The Food and Drug Administration (FDA) said it will reconsider its decision to remove Eli Lilly’s blockbuster weight loss and ...

Unemployed people will be given weight-loss jabs under Government plans to get them back to work. Wes Streeting, the Health ...

Hims & Hers Health Inc (NYSE:HIMS) shares are trading higher Monday after the U.S. Food and Drug Administration said it would ...

The agency agreed in court to allow compounding companies to continue producing copycat versions of Lilly’s fast-selling medicines while it reevaluates its recent decision to declare the drugs back in ...

The reconsideration follows an Oct. 11 lawsuit that prompted U.S. District Judge Mark Pittman to temporarily halt legal proceedings to give the FDA time to reassess its ruling.

In accepting the FDA’s motion, U.S. District Judge Mark Pittman put on hold a lawsuit filed by the Outsourcing Facilities ...

As with any new drug, parents and doctors may worry that the use of GLP-1 weight-loss meds by children and teens might ...

The FDA's decision came in response to a lawsuit filed in federal court in Fort Worth, Texas, by the Outsourcing Facilities Association, a trade association focused on ensuring access to compounded ...